Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024 16:45 ET
|
Certara
Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024 16:15 ET
|
Certara
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second...
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024 08:00 ET
|
Certara
Certara today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers.
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024 16:15 ET
|
Certara
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global...
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024 08:00 ET
|
Certara
Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.
Certara Reports First Quarter 2024 Financial Results
May 07, 2024 16:15 ET
|
Certara
PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. ...
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
April 16, 2024 08:00 ET
|
Certara
Certara Cloud is a unifying platform that integrates Certara's scientific software. Clients use a single ID to access and manage their licensed software.
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
April 09, 2024 16:15 ET
|
Certara
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...
Certara Reports Fourth Quarter 2023 Financial Results
February 29, 2024 16:10 ET
|
Certara
PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023. ...
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
February 01, 2024 16:30 ET
|
Certara
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and...